Evolva Holding SA

Swiss Stock Exchange EVE.SW

Evolva Holding SA Share Price on February 05, 2025: USD 1.38

Evolva Holding SA Share Price is USD 1.38 on February 05, 2025, a 7.27% change year over year. Share price reflects current trading price of a company's stock; influenced by market dynamics and company performance.
  • Evolva Holding SA 52-week high Share Price is USD 1.38 on February 05, 2025, which is 0.00% below the current Share Price.
  • Evolva Holding SA 52-week low Share Price is USD 1.12 on January 14, 2025, which is -18.75% below the current Share Price.
  • Evolva Holding SA average Share Price for the last 52 weeks is USD 1.24.
Key data
Date Share Price Price to Earnings Ratio (P/E) Price to Sales Ratio (P/S) Price to Book Ratio (P/B)
Market news
Loading...
SV Wall Street
Swiss Stock Exchange: EVE.SW

Evolva Holding SA

CEO Mr. Gerhard Lobmaier
IPO Date May 3, 2005
Location Switzerland
Headquarters Duggingerstrasse 23
Employees 49
Sector Consumer Discretionary
Industries
Description

Evolva Holding SA discovers, researches, develops, and commercializes nature-based ingredients for use in flavor and fragrances, health ingredients, health protection, and other sectors in Switzerland, the United States, and internationally. It offers various ingredients comprising Veri-te Resveratrol, a nature-made polyphenol that occurs naturally in grapes and other plants, including peanuts, cranberries, and berries; L-Arabinose, a flavoring agent used in Maillard reaction; Valencene, an aroma component of citrus fruit and citrus-derived odorants; Nootkatone, an aroma ingredient of grapefruit obtained via biochemical oxidation of valencene; and Vanillin, a primary component of vanilla bean extract. The company was founded in 2004 and is headquartered in Reinach, Switzerland.

Similar companies

BSLN.SW

Basilea Pharmaceutica AG

USD 45.08

2.29%

SANN.SW

Santhera Pharmaceuticals Holding AG

USD 18.70

3.10%

MBTN.SW

Meyer Burger Technology AG

USD 1.86

3.49%

StockViz Staff

February 6, 2025

Any question? Send us an email